Adjuvant Capital

Investment firm

Adjuvant Capital

Private equity, Venture capital

WebsiteCrunchbase profileNew York·United States9known portfolio companies4people tracked17co-investors

Adjuvant Capital is a private equity firm and venture capital firm. Based in New York, United States. Among the 9 companies in the known portfolio are 54gene, Memo Therapeutics, Antiva Biosciences, Codagenix, LimmaTech Biologics and Minervax.

Is Adjuvant Capital a fit for your startup?

Paste your website. AI checks the fit and scores every other investor too.

Investment focus

Contacts

kaz***@***.comAvailable after registration.
Get contact

Who to pitch at Adjuvant Capital

Adjuvant Capital portfolio companies (9)

  • 54gene
  • Memo Therapeutics
  • Antiva Biosciences
  • Codagenix
  • LimmaTech Biologics
  • Minervax
  • Curevo
  • InDevR
  • VitriVax

Co-investors

Funds that share portfolio companies with Adjuvant Capital.

Similar funds

Showing 20 of 100

About Adjuvant Capital

The firm's listing covers sector Healthcare, and focus areas Biotech, Collaboration, Drug Discovery and Genetics; known deals cluster at Growth, Seed and Series A.

Of the 4 people on file at Adjuvant Capital, Charlie Petty (Co-Founder & Venture Partner), Kabeer Aziz (Co-founder & Partner) and Glenn Rockman (Founder and Managing Partner) are listed as the contacts to approach first.

Adjuvant Capital shares portfolio companies with 17 other investment firms, among them KdT Ventures, Sunstone Life Science Ventures and Sirona Capital.

Frequently asked questions

What is Adjuvant Capital?

Adjuvant Capital is a private equity firm and venture capital firm based in New York, United States, with a known portfolio of 9 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.

What does Adjuvant Capital invest in?

Listed sectors include Healthcare; listed focus areas include Biotech, Collaboration, Drug Discovery and Genetics. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.

What stage does Adjuvant Capital invest at?

The known deals of Adjuvant Capital include Growth, Seed and Series A rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.

Who should I pitch at Adjuvant Capital?

3 of the 4 people on file at Adjuvant Capital are listed as contacts for the firm. All 4 have their own profile page.

How do I contact Adjuvant Capital?

Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 4 people attached to the firm have their own pages, each showing whether an address is on file for them.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal